Patents by Inventor John A. Copland, III

John A. Copland, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Compositions For Preparing Pancreatic Insulin Secreting Cells
    Publication number: 20080241107
    Abstract: The present invention concerns the use of transdifferentiated cells to treat pancreatic diseases. More particularly, it provides methods for the culture and transdifferentiation of human cord blood, cells into insulin-secreting cells. It also concerns the endocrine hormones, such as insulin, produced by such cultures, and the use of the transdifferentiated cells in the treatment of diabetes.
    Type: Application
    Filed: January 24, 2005
    Publication date: October 2, 2008
    Inventors: John A. Copland III, Randall J. Urban, Yvonne H. Bodenburg
  • Clinical use of oxytocin alone or in combination to treat bone disorders
    Patent number: 6333313
    Abstract: The present invention details the use of oxytocin or oxytocin analogs as a novel therapeutic regimen for the treatment of various bone diseases and for assisting in bone remodeling. Oxytocin and oxytocin analogs can be administered alone or in combination with other agents used to treat bone diseases or aid in bone remodeling. In addition, agents which induce endogenous oxytocin release are also contemplated in the present invention for treatment of bone diseases and for assisting in bone remodeling. Diseases and conditions that are contemplated to benefit from the present invention include osteoporosis, osteopenias, bone fractures and bone remodeling surgery.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: December 25, 2001
    Assignee: Board of Regents, The University of Texas System
    Inventors: John A. Copland, III, Kirk Lorne Ives, David J. Simmons, Melvyn Soloff